Jim Cramer Says Hold Onto This Biotech Stock: 'I Don't Understand Why It's So Inexpensive'
Portfolio Pulse from Avi Kapoor
Jim Cramer, on CNBC's 'Mad Money Lightning Round,' recommended holding onto Moderna (MRNA) and BioNTech (BNTX), citing their inexplicably low prices and leadership. He suggested Becton, Dickinson (BDX) over Amphastar Pharmaceuticals (AMPH) for stability. Cramer praised Pan American Silver (PAAS) as the top silver company and endorsed Starwood Property Trust (STWD) for its dividend. He was bullish on Lockheed Martin (LMT), simply advising to 'just buy it.' The article also reports recent price actions of these stocks.
January 17, 2024 | 1:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Cramer recommends Becton, Dickinson for its stability compared to Amphastar Pharmaceuticals, which could have a positive impact on BDX's stock.
Cramer's recommendation of BDX as a stable investment over AMPH may increase investor confidence in BDX, potentially leading to a rise in its stock price.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
POSITIVE IMPACT
Jim Cramer is puzzled by BioNTech's low price and recommends holding onto it, which could indicate an undervalued stock with upside potential.
Cramer's confusion over BNTX's low price and his recommendation to hold may lead investors to believe the stock is undervalued, potentially increasing its price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jim Cramer is bullish on Lockheed Martin, advising to 'just buy it,' which could lead to a positive short-term impact on LMT's stock.
Cramer's bullish stance and simple advice to buy LMT may boost investor confidence and demand for the stock, potentially increasing its price.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
Jim Cramer recommended holding onto Moderna, citing confidence in its leadership, which could signal a positive outlook for the stock.
Cramer's endorsement, based on leadership quality, may increase investor confidence and demand for MRNA, potentially driving up its price.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jim Cramer labeled Pan American Silver as the 'best one' among silver companies, which could positively influence PAAS's stock in the short term.
Cramer's high praise for PAAS as the top silver company may attract investor attention and investment, possibly driving up the stock price.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 75
NEUTRAL IMPACT
Cramer is willing to wait for a turnaround in Starwood Property Trust, valuing its dividend, which could maintain investor interest in STWD's stock.
Cramer's willingness to wait for STWD's turnaround, based on its dividend, may keep investor interest steady, likely resulting in a neutral impact on the stock price.
CONFIDENCE 65
IMPORTANCE 55
RELEVANCE 65
NEGATIVE IMPACT
Cramer is less enthusiastic about Amphastar Pharmaceuticals, suggesting Becton, Dickinson (BDX) as a more stable alternative, which could negatively impact AMPH's stock.
Cramer's preference for BDX over AMPH due to stability concerns may lead to a negative perception of AMPH, potentially decreasing investor interest and its stock price.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70